Search Results - Dexamethasone OR corticosteroid

PubPharm (22)

1

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia : a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial

in: Intensive care medicine | (10.11.2021)

by Granholm, A. | Munch, M. | Myatra, S. | +43

2

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia : a randomized clinical trial

in: Intensive care medicine | Vol. 47, No. 11 (2021), p. 1258-1270

by Rosas, I. | Diaz, G. | Gottlieb, R. | +18

3

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

enthalten in: Intensive care medicine | 2021

by Rosas, I. | Diaz, G. | Gottlieb, R. | +18

4

Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis

in: Intensive care medicine | Vol. 47, No. 8 (2021), p. 819-834

by Verweij, P. | Brüggemann, R. | Azoulay, E. | +25

5

Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis

enthalten in: Intensive care medicine | 2021

by Verweij, P. | Brüggemann, R. | Azoulay, E. | +25

6

Corticosteroids in COVID-19 and non-COVID-19 ARDS : a systematic review and meta-analysis

in: Intensive care medicine | Vol. 47, No. 5 (2021), p. 521-537

by Chaudhuri, D. | Sasaki, K. | Karkar, A. | +17

7

Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis

enthalten in: Intensive care medicine | 2021

by Chaudhuri, D. | Sasaki, K. | Karkar, A. | +17

8

Ten reasons why corticosteroid therapy reduces mortality in severe COVID-19

in: Intensive care medicine | Vol. 47, No. 3 (2021), p. 355-356

by Añón, J. | Villar, J.

CommentOn: Intensive Care Med. 2020 Nov;46(11):2067-2070. - PMID 33026460

9

The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19. Author's reply

in: Intensive care medicine | Vol. 47, No. 3 (2021), p. 357-358

by Meduri, G. | Chrousos, G. | Arabi, Y.

CommentOn: Intensive Care Med. 2021 Mar;47(3):355-356. - PMID 33388793

10

COVID-19 increased the risk of ICU-acquired bloodstream infections : a case-cohort study from the multicentric OUTCOMEREA network

in: Intensive care medicine | Vol. 47, No. 2 (2021), p. 180-187

by Buetti, N. | Ruckly, S. | de Montmollin, E. | +6

ErratumIn: Intensive Care Med. 2021 May;47(5):640. - PMID 33688994

1
2
3
Next »
[3]